SCHEMBL21362648

SCHEMBL21362648

Cc1ccc(C(O)c2ccc(F)cc2)c(Br)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.39
LMNA P02545 2/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ATM Q13315 2/20 0.35
KMT2A Q03164 1/20 0.35
BRD4 O60885 2/20 0.35
TRPA1 O75762 1/20 0.34
CHRM1 P11229 1/20 0.34
SLC6A2 P23975 1/20 0.34
ADRA1A P35348 1/20 0.34
HTR2B P41595 1/20 0.34
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
AOC3 Q16853 1/20 0.33
CREBBP Q92793 1/20 0.33
NR3C1 P04150 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157837 0.87 ACHE (0.39) ACHELMNAALDH1A1SMN1; SMN2TDP1
SCHEMBL11867787 0.86 HDAC3 (0.36) ATMKMT2ABRD4SLC6A2THRA
SCHEMBL11859495 0.83 MLKL (0.45) LMNAALDH1A1SMN1; SMN2TDP1KMT2A
SCHEMBL1584767 0.83 ACHE (0.41) ACHELMNAALDH1A1SMN1; SMN2TDP1
SCHEMBL20158083 0.81 TRPA1 (0.34) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL21362759 0.81 LMNA (0.43) ACHELMNAALDH1A1SMN1; SMN2TDP1
SCHEMBL11857823 0.81 APLNR (0.44) ACHELMNAALDH1A1KMT2ATHRA
SCHEMBL20158076 0.80 POLB (0.40) LMNAKMT2ABRD4TRPA1CHRM1
SCHEMBL20157925 0.80 ALDH1A1 (0.36) ACHELMNAALDH1A1TRPA1CHRM1
SCHEMBL21352143 0.79 BRD4 (0.34) ATMKMT2ABRD4THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed